Beam Therapeutics
Biotech · 8 tracked clinical trials
Clinical Pipeline
| Trial | Phase | Status | Indication |
|---|---|---|---|
| NCT06389877 | PHASE1, PHASE2 | RECRUITING | Alpha 1-Antitrypsin Deficiency |
| NCT05456880 | PHASE1, PHASE2 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease |
| NCT06735755 | PHASE1, PHASE2 | RECRUITING | Glycogen Storage Disease Type Ia |
| NCT05885464 | PHASE1, PHASE2 | ACTIVE_NOT_RECRUITING | Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia |
| NCT06934382 | PHASE1 | RECRUITING | T-Cell Acute Lymphoblastic Leukemia/Lymphoma |
| NCT07304791 | PHASE1 | RECRUITING | Healthy Subjects, Healthy Participant Study |
| NCT07373639 | — | RECRUITING | Hemoglobinopathy, Sickle Cell Disease |
| NCT06071377 | — | RECRUITING | Sickle Cell Trait |